121 related articles for article (PubMed ID: 7888309)
1. Ovarian cancer in the elderly patient.
Moore DH
Oncology (Williston Park); 1994 Dec; 8(12):21-5; discussion 25, 29-30. PubMed ID: 7888309
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
[TBL] [Abstract][Full Text] [Related]
4. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
5. Ovarian, uterine, and cervical cancer in the elderly woman.
McGonigle KF; Lagasse LD; Karlan BY
Clin Geriatr Med; 1993 Feb; 9(1):115-30. PubMed ID: 8443730
[TBL] [Abstract][Full Text] [Related]
6. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
Venesmaa P
Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
[TBL] [Abstract][Full Text] [Related]
7. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
Orr JW; Orr P; Kern DH
Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced ovarian carcinoma in the elderly.
Marchetti DL; Lele SB; Priore RL; McPhee ME; Hreshchyshyn MM
Gynecol Oncol; 1993 Apr; 49(1):86-91. PubMed ID: 8482566
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
10. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ
Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108
[TBL] [Abstract][Full Text] [Related]
11. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
12. Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument.
Elit LM; Levine MN; Gafni A; Whelan TJ; Doig G; Streiner DL; Rosen B
Gynecol Oncol; 1996 Sep; 62(3):329-35. PubMed ID: 8812525
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer.
Uyar D; Frasure HE; Markman M; von Gruenigen VE
Gynecol Oncol; 2005 Sep; 98(3):403-8. PubMed ID: 16000216
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
15. Surgery for elderly patients with ovarian cancer.
Bäuerle MG; Kreienberg R; Volm T
Curr Womens Health Rep; 2003 Feb; 3(1):39-42. PubMed ID: 12521549
[TBL] [Abstract][Full Text] [Related]
16. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.
Moore DH; Kauderer JT; Bell J; Curtin JP; Van Le L
Gynecol Oncol; 2004 Aug; 94(2):368-74. PubMed ID: 15297174
[TBL] [Abstract][Full Text] [Related]
17. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study.
Maas HA; Kruitwagen RF; Lemmens VE; Goey SH; Janssen-Heijnen ML
Gynecol Oncol; 2005 Apr; 97(1):104-9. PubMed ID: 15790445
[TBL] [Abstract][Full Text] [Related]
18. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
[TBL] [Abstract][Full Text] [Related]
19. Surgical care of elderly women with ovarian cancer: a population-based perspective.
Díaz-Montes TP; Zahurak ML; Giuntoli RL; Gardner GJ; Gordon TA; Armstrong DK; Bristow RE
Gynecol Oncol; 2005 Nov; 99(2):352-7. PubMed ID: 16055176
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
